CDC’s Committee Member Dr. Chen Should be Removed Immediately Due to Conflict of Interest

Dr. Wilbur H. Chen, whose conflicts of interest include accepting $437,250 from vaccine makers, should be removed immediately from the Advisory Committee on Immunization Practices.

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

To receive Global Research’s Daily Newsletter (selected articles), click here.

Visit and follow us on Instagram at @crg_globalresearch.

***

 

Dr. Wilbur H. Chen wants you to know that he’s very upset (see comment’s section)!

He’s upset the peasants have access to email!

He’s upset the peasants have access to common sense and reason!

He’s upset the peasants actually read scientific studies for themselves!

And he’s very upset that the peasants are speaking to him without his express written permission!

Apparently, he’s also clairvoyant (like Santa) because he knows what you are writing before you even send it to him, so he has set up an auto-reply on his email account to let you know he’s very important, he gets lots of emails and he does not like “misinformation.”

Chen defines “misinformation” as anything that contradicts the Pharma narrative. Chen is adamant that nothing be allowed to pierce his protective Pharma information bubble.

I’m reminded of the phrase, “Methinks thou doth protest too much.”

What Chen is actually mad about is that he got caught with his hand in the cookie jar.

A search of the government website Open Payments reveals Chen accepted $437,250.70 from Emergent BioSolutions and GlaxoSmithKline (GSK) in 2020.

Research funding

GSK is one of the four largest vaccine makers in the world. GSK makes the incredibly toxic Hep B vaccine (Engerix-B), the troubled HPV vaccine (Cervarix), a meningococcal vaccine that is loaded with aluminum (Bexsero) and various flu vaccines among others.

GSK is also working on a COVID-19 vaccine that is now in Phase 3 clinical trials.

All of GSK’s products must go before the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP), that Chen sits on, in order to be approved.

Emergent BioSolutions is a contract manufacturer that makes vaccines for others including the Johnson & Johnson (J&J) COVID-19 vaccine that has been linked to blood clots and a bleeding disorder.

Emergent BioSolutions has an abysmal safety record. Even though federal regulators are generally like Mr. Magoo when it comes to spotting safety problems, the issues at Emergent’s plant in Baltimore were so egregious that earlier this year the U.S. Food and Drug Administration shut down the plant and ordered J&J to take it over and run it themselves.

The FDA also ordered 75 million doses of COVID-19 vaccines manufactured at that plant be destroyed because of contamination. All of the vaccines manufactured at the Emergent BioSolutions plant must first be approved by the ACIP where Chen is a member.

This is completely unacceptable. According to the Bureau of Labor Statistics, there were 27,550 pediatricians employed in the U.S. There is absolutely no reason for the ACIP to utilize a person with such extensive financial conflicts of interest.

The CDC) must be above reproach in order to have any credibility with the general public. Sadly the CDC appears to do whatever it can get away with — a classic example of the fox guarding the henhouse.

The fact that these decisions involve the health of our children makes corruption all the more appalling.

Please contact the following four officials (as well your elected representatives) to let them know that you are troubled by Chen’s extensive financial conflicts of interest and please ask that he be removed from the ACIP before it meets on Tuesday, Nov. 2.

Dr. Rochelle Walensky
Director, Centers for Disease Control and Prevention
Roybal Building 21, Rm 12000
1600 Clifton Rd, Atlanta, GA 30333
phone: (404) 639-7000
[email protected]

Xavier Becerra
Secretary, Health and Human Services
200 Independence Avenue S.W., Washington, D.C. 20201
c/o Sean McCluskie
[email protected]

Captain Amanda Cohn
Chief medical officer
National Center for Immunizations and Respiratory Diseases
Centers for Disease Control and Prevention
1600 Clifton Rd, Atlanta, GA 30333 MS C-09
phone: (404) 639-6039
fax: (404) 315-4679
[email protected]
[email protected]

Grace Lee, M.D.
Chair, Advisory Committee on Immunizations Practices
Center for Academic Medicine
Pediatric Infectious Diseases, Mail Code: 5660
453 Quarry Road, Stanford, CA 94304
phone: (650) 497-0618
phone: (650) 498-6227
fax: (650) 725-8040
[email protected]

It is beyond alarming that the ACIP has failed to properly monitor financial conflicts of interest amongst its members. All prior ACIP votes involving Chen should be reviewed by an independent outside review board to see if they must be thrown out because of this blatant corruption.

The CDC should also examine and release publicly all financial conflict of interest statements from all remaining ACIP members to determine if there are additional problems before Tuesday.

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image is from CHD


Articles by: Toby Rogers

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]